Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi DJ Switzerland Titans 30 UCITS ETF Dist

C030 · LU2611732632 · class UCITS ETF Dist · CHF · domicile Luxembourg
Equity · SwitzerlandSFDR art. 6
Index tracked: Dow Jones Switzerland Titans 30 Total Return Index
TER
0.25%+ trans. 0.02%
Fund size
220 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Distributingannual
Launch 7 Dec 2023 · costs from the KID as of 2 Sept 2026 · 35 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of the Dow Jones Switzerland Titans 30 Total Return Index (the “Index”), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index: dividends net of tax paid by the Index constituents are included in the Index return. The Index is composed of the…

Performance since series start (in euro) — base 100

29 Nov 20238 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202420252026154100147
High 154 (3 Jul 2026) · low 100 (29 Nov 2023) · last 147. Past performance is not indicative of future results.

Returns in euro

1 year+15.6%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+47.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.60%11.60%
Max drawdown−11.18%−11.18%
Sharpe1.041.04
Sortino1.511.51
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · C030 · LU26117326321
RebalixC030 · LU2611732632 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
YearFundIndexTD
2025+16.62%+16.99%−0.36%

Distributions · per share, in CHF

Frequency: annual · last 12 months: 2.29 CHF (1.23% of NAV) · last ex-date 9 Dec 2025
YearPaymentsTotal (CHF)Dividend yield
202512.29+1.53%
202412.23+1.61%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 35 securities · top-10 weight = 71.3%
Top holdingsWeight
NOVARTIS AG-REG10.3%
UBS GROUP AG9.9%
ROCHE HOLDING AG - GENUSSS CHF9.6%
NESTLE SA-REG9.2%
ABB LTD-REG8.9%
CIE FINANCIERE RICHEMO-A REG7.6%
ZURICH INSURANCE GROUP AG6.9%
SWISS RE AG3.2%
LONZA GROUP AG-REG3.0%
HOLCIM LTD2.7%
Countries (% of fund)
Switzerland100.0%
Sectors (% of fund)
Health Care32.0%Financials25.4%Industrials14.7%Consumer Staples10.7%Consumer Discretionary8.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
C030 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 17 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU2611732632/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU2611732632/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU2611732632/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU2611732632
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · C030 · LU26117326322